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RePublic reporting of health care data continues to proliferate as consumers and other stakeholders seek information on the
quality and outcomes of care. Medicare’s Hospital Compare website, the U.S. News & World Report hospital rankings, and
several state-level programs are well known. Many rely heavily on administrative data as a surrogate to reﬂect clinical
reality. Clinical data are traditionally more difﬁcult and costly to collect, but more accurately reﬂect patients’ clinical
status, thus enhancing the validity of quality metrics. We describe the public reporting effort being launched by the
American College of Cardiology and partnering professional organizations using clinical data from the National
Cardiovascular Data Registry (NCDR) programs. This hospital-level voluntary effort will initially report process of care
measures from the percutaneous coronary intervention (CathPCI) and implantable cardioverter-deﬁbrillator (ICD)
registries of the NCDR. Over time, additional process, outcomes, and composite performance metrics will be reported.
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ABBR EV I A T I ON S
AND ACRONYMS
ACC = American College of
Cardiology
CABG = coronary artery bypass
graft
ICD = implantable
cardioverter-deﬁbrillator
NCDR = National
Cardiovascular Data Registry
PCI = percutaneous coronary
intervention
STS = Society of Thoracic
Surgeons
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206P ublic reports of health care data, qual-ity metrics, and outcomes have beenavailable for over a decade (1). The
Federal government, some state depart-
ments of health, and numerous private orga-
nizations regularly report measures of health
care–related quality including outcomes us-
ing publicly available ﬁnancial, administra-
tive, and descriptive data, and often apply
proprietary methods. Administrative data
are readily available to payers and thus are
attractive sources of information. Unfortu-
nately, many studies have shown that
administrative data are payer and marketspeciﬁc, use old and sometimes nonactionable data,
and may poorly reﬂect acute severity of illness, cor-
rect diagnosis, and clinical outcomes (2–5). Although
considerable ﬁnancial resources are spent on such re-
ports, it is not clear how and to what extent individ-
ual consumers use this information (6).
Professional organizations including the American
Medical Association, the Society of Thoracic Sur-
geons (STS), the American Heart Association, and the
American College of Cardiology (ACC) have articu-
lated key principles to guide public reporting initia-
tives, as have several public and private initiatives
(7–9). Fundamental to these principles is the use of
clinical data whenever possible and returning
timely, benchmarked reports to participating in-
stitutions to support their quality improvement
programs. Since 1997, the ACC has developed a suite
of registries within the National Cardiovascular Data
Registry (NCDR) program that collect, audit, bench-
mark, and report clinical data and outcomes on
speciﬁc cardiovascular procedures and diagnoses to
participating institutions (10). This has occurred in
partnership with the Society for Cardiovascular
Angiography and Interventions for the CathPCI
Registry, focused on percutaneous coronary inter-
ventional (PCI) patient care, and the Heart Rhythm
Society for the ICD Registry, focused on implantable
cardioverter-deﬁbrillator (ICD) patient care. The
timeliness and clinical detail of these data and re-
ports are superior to administrative data. Facilities
submit clinical data to the NCDR and receive quar-
terly reports of their own data compared with
aggregated national data for quality benchmarking.
Traditionally, NCDR data have only been available
directly to participant facilities, consortia, or health
plans. Several scientiﬁc publications from the NCDR
have reported aggregate data to identify quality
gaps at the national level to stimulate efforts
to improve care (11). Now, the ACC, in partner-
ship with Society for Cardiovascular Angiographyand Interventions and Heart Rhythm Society, has
developed a pathway for participant institutions to
voluntarily publicly report their NCDR hospital-level
data (1,12).
RATIONALE FOR PUBLIC REPORTING
The most compelling justiﬁcation for public reporting
is the right of an individual to know about the care
that he or she is likely to receive. With the current
national emphasis on the quality, accountability, and
cost-effectiveness of health care, the various stake-
holders and consumers of health care are eager to
obtain information about health care facilities and
providers. This has created a “market” for public
reporting that, at present, is not well coordinated as
different stakeholders have somewhat divergent
goals and varying conﬁdence in the utility of
nonclinical data sources (Figure 1). Many public
reports use data that are several years old, were not
designed for clinical performance reporting, or are
constructed using proprietary analytic methods that
are difﬁcult to reproduce or verify. This diverse
reporting environment can confuse patients and
purchasers, has the potential to misdirect our focus
away from the rights of the individual patient, and
has led to divergent public rankings of the same
facility in different reporting systems (13).
Hospital-level public reporting, in its various
formats, is now familiar to most clinicians. Public
reporting of individual provider data is becoming
more prevalent (14). However, physician-level re-
porting has additional challenges, such as attributing
process and outcome of care metrics to speciﬁc
providers and addressing variability in individual
metrics in smaller practice groups or for individuals.
Public reporting is primarily based upon the belief
that accessible, transparent high-quality information
will affect decisions and behaviors of the various
stakeholders, ultimately resulting in an improvement
in health care delivery and outcomes. However, use
of this information by various segments of the pop-
ulation is variable, and the effect of this information
on patients’ decision-making is uncertain (15,16).
Reporting efforts to deﬁne the “best of the best” can
motivate an unnecessary performance-reporting
race and may not provide the information most
patients are seeking. Patients’ quality concerns
seem more focused on access to empathetic, inter-
active providers and the availability of local com-
mon services that meet an acceptable standard of
care (17–20). As public reporting efforts continue to
grow, the ACC and its partnering organizations are
committed to a leadership role in quality of care
FIGURE 1 The 4 “Ps” of Public Reporting
The 4 “Ps”
of Public ReportingPayers Patients
Policymakers
PoliticiansPhysicians But, everyone has a different idea and
agenda to arrive at the best solution
Everyone wants:
The best care
(evidence-based &
improved outcomes)
at the lowest cost,
delivered safely,
with transparency
Patients, payers, and policymakers/politicians are all interested in public reporting but for
different reasons. Physicians, the fourth “P,” are shown differently, as there are mixed
feelings and concerns about the effect of public reporting.
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207reporting, consistent with their principles of public
reporting (7,11).
PUBLIC REPORTING PROGRAMS AND
DATA SOURCES
Many programs, such as the Centers for Medicare &
Medicaid Services effort, reported on the Medicare
website, utilize administrative data (billing claims) as
surrogates for clinical information for some reported
metrics as these data are readily available, are inex-
pensive, and cover broad populations (21). However,
this approach has several shortcomings (2–5). First,
invoices are ﬁnancial instruments and are not princi-
pally designed to serve as indicators for clinical
diagnoses, disease severity, or acuity of illness. Sec-
ond, conditions and complications present before or
during hospitalization have been difﬁcult to verify,
although this may now be mitigated with the new
“present on admission” codes. Third, although claims
data can identify tests that are ordered and billed,
they do not include test results. Finally, clinical
decisions or “appropriateness” are not documented.
The Centers for Medicare & Medicaid Services
now also reports total payments to physicians, drug
prescribing behaviors and costs, and payments
received by physicians from industry (22). Other pro-
grams, such as the Leapfrog Group, report survey data
submitted voluntarily by hospitals regarding high-risk
surgeries, maternity care, hospital-acquired in-
fections, and compliance with safety measures (23).
Numerous independent groups produce a variety of
reports or promote websites where patients can report
their experiences with hospitals or individual pro-
viders. The methodology for many of these programs
is typically proprietary, is not explained, and over-
sight, if any, is not characterized. Some organizations
focus on cost-proﬁling procedures at hospitals and by
individual physicians without attention to quality,
which is ultimately most important to patients (24).
In comparison, relatively few programs use clinical
data to develop a public report. One of the ﬁrst was the
Northern New England Cardiovascular Disease Study
Group, which maintains registries for all patients
receiving coronary artery bypass grafting (CABG), PCI,
and heart valve replacement surgery at 7 New England
hospitals and provides a public report of CABG results
on their website (25). More recently, the Clinical
Outcomes Assessment Program reported clinical data
from the NCDR and STS collected from 35 hospitals in
Washington State (26). In Massachusetts, public
reports utilizing NCDR and STS clinical data at all
nonfederal acute care hospitals performing CABG
surgery and PCI have been posted since 2002 and 2003,respectively, and the New York State Department of
Health has issued CABG reports since 1992 and PCI
reports since 1995 (27,28). The STS has maintained a
clinical database on cardiac surgical procedures since
1989 and, in 2011, began a voluntary public reporting
program in collaboration with Consumer Reports, a
program that has been well received (29,30).
The Patient Protection and Affordable Care Act of
2010 includes a framework for quality improvement
that embraces public reporting of health care quality
information. More recently, the Medicare Access and
Children’s Health Insurance Program Reauthorization
Act of 2015 (known as MACRA) incorporates a merit-
based incentive payment system that will encourage
alternative payment models compared with the
traditional fee-for-service model. Payment adjust-
ments will be based on 4 performance categories
(clinical quality, meaningful use, resource use, and
clinical practice improvement), creating an environ-
ment with an untested effect on access and care
quality, but rich with public reporting opportunities.
BENEFITS AND CONCERNS RELATED TO
PUBLIC REPORTING
The merits of public reporting are debated. Advocates
argue that public reporting enables patients to
identify the best physicians and hospitals, simulta-
neously giving clinicians and health care
organizations incentives to improve quality (31). Some
studies have shown associations between public
TABLE 1 Operational Rules for the NCDR Public Reporting Program
Facility identiﬁcation All facilities participating in at least 1 NCDR registry will have an opening page that identiﬁes the site, address,
contact information, and services performed at the facility based upon self-reported information. A link to
Google maps is provided. Facilities may provide a link to their organization’s website if desired.
Facility participation Facility participation in public reporting is voluntary. Facilities that choose not to participate in reporting will be
designated as “not participating in ACC/NCDR public reporting program”
Registry participation Facility participation in each of the NCDR registries will be identiﬁed. The terms used are “participating” if the service
is performed at the facility and data are submitted to the corresponding NCDR registry; “not participating” if the
service is performed at the facility, but the facility does not submit data to the associated registry; and “does not
perform service” if the service is not performed at the facility
Registry reporting Facilities submitting data to more than 1 registry may choose to participate in public reporting for each registry
individually. However, all individual metrics within a registry will be reported provided they meet the minimum
sample size requirements. This initial launch will be limited to measures from the CathPCI and ICD registries.
Facility review period Facilities will receive data contained in their public report a minimum of 30 days before the release date. During that
review period, facilities will decide to opt in for this cycle of public reporting.
Reporting frequency For public reporting, data are displayed using a 12-month, calendar year performance period. Public reports will be
issued and updated once per calendar year based on the most recent calendar year data available.
Data requirements Data are evaluated for completeness and logic before entry into an NCDR registry. Data are entered quarterly, and
only those data submissions passing these checks are accepted into the registry. For public reporting, facilities
must have submitted acceptable data for a minimum of 9 months during the calendar year period. Facilities
failing this requirement are ineligible for public reporting.
Rating format The public display will use a 1- to 4-star rating scheme. Each metric from a facility will have a star rating assigned;
there will be no zero star ratings, and only whole star ratings are presented. Additional details about the rating
including conﬁdence interval estimates are provided by links to web pages with detailed explanations.
Hospital comparison
data
Each hospital will receive a performance score for each reported metric converted to the star rating. This score can be
used to assess individual hospital performance compared with a benchmark of other facilities eligible to report data.
A higher performance score means better performance on the metric.
State comparison data Each state also receives a quality performance score converted to a star rating. This score can be used to assess the
performance of all hospitals in the state compared with a benchmark of all states with registry data. A higher
performance score means better performance on the metric for all hospitals across the state.
International sites International sites participating in the NCDR are not included in comparison data.
ACC ¼ American College of Cardiology; CathPCI ¼ Catheterization and Percutaneous Coronary Intervention; ICD ¼ implantable cardioverter-deﬁbrillator; NCDR ¼ National
Cardiovascular Data Registry.
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208reporting and higher quality of care (32,33). Oppo-
nents counter that data used in some measures lack
adequate clinical granularity to accurately reﬂect
quality or that outcomes reporting may encourage
denial of care to the sickest patients whomight beneﬁt
most from treatment, but are also at highest risk for
poor outcomes (34–41). Risk adjustment is intended to
correct for the inclusion of sicker patients (42,43), but
in practice, risk adjustment is imperfect; variability in
how high-risk features are documented in the medical
record and then abstracted into registry data are
common (44–46). For complex diseases, the same fa-
cility may be rated differently when reported and
analyzed by various commercial risk models, even
when using the same administrative data (13).
Although recognizing the challenges to developing
accurate and meaningful reporting, the ACC and its
partnering organizations believe that a thoughtful,
measured public reporting program, which uses clin-
ical data with scientiﬁcally openmethodology, subject
to iterative improvement and oversight by profes-
sional organizations, has beneﬁts and hopefully can
minimize the potential unintended consequences.
Patients, payers, health care quality organizations,
and the government all desire transparent andaccurate reporting of the performance of cardiovas-
cular programs. Clinicians and patients can beneﬁt
from access to this information as long as it is correct
and provided in a fair and understandable format. The
ACC believes it has a responsibility to move the pro-
fession toward acceptance of public reporting by using
clinical data from the NCDR. Therefore, after careful
study of the feasibility of public reporting using NCDR
data, the ACC and its partnering organizations estab-
lished the Public Reporting Advisory Group to oversee
the implementation of the public reporting program
and guide operational decisions necessary to achieve
these goals. A summary of the key decisions made by
the Public Reporting Advisory Group and the structure
of the public reporting program are described in this
paper.
STRUCTURE OF THE
PUBLIC REPORTING PROGRAM
AND THE INITIAL METRICS REPORTED
Major operational decisions about the structure of
the reporting program are summarized in Table 1.
Hospital participation in public reporting of their
NCDR data is voluntary. Because metrics reported in
TABLE 2 Initial CathPCI Public Reporting Metrics
Metric (NCDR Number)
NQF Endorsed
Measure Number CardioSmart Title CardioSmart Description
Number of PCI/angioplasty
procedures (N/A)
N/A Number of PCI/angioplasty procedures
performed during the calendar year.
The number of PCI/angioplasty procedures that a site
performs does not necessarily indicate higher quality,
but it may be an indication of how experienced this
site is with the procedure.
Aspirin at discharge (8) 0964 Use of aspirin to reduce the chance
of blood clots after PCI/angioplasty.
Patients should be prescribed aspirin to reduce the risk of
heart attacks caused by blood clots in new stents after
having a PCI/angioplasty—unless there is a reason not
to use the medicine (such as an allergy).
This score shows how well this facility is following this
guideline—higher is better. Patients who cannot take
aspirin are excluded from the calculation.
P2Y12 inhibitor at discharge (9) 0964 Use of a P2Y12 inhibitor medication to
reduce the chance of blood clots after
PCI/angioplasty.
Patients should be prescribed a P2Y12 inhibitor medication
to reduce the risk of heart attacks caused by blood clots
in new stents after having a PCI/angioplasty—unless there
is a reason not to use the medicine (such as an allergy).
This score shows how well this facility is following this
guideline—higher is better. Patients who cannot take
P2Y12 inhibitor medicines are excluded from the calculation.
Statins at discharge (10) 0964 Use of a statin to decrease cholesterol
after PCI/angioplasty.
Patients should be prescribed a statin to decrease cholesterol
and reduce the risk of heart attacks after having a
PCI/angioplasty—unless there is a reason not to use
the medicine (such as an allergy).
This score shows how well this facility is following this
guideline—higher is better. Patients who cannot take
statin medications are excluded from the calculation.
Composite of all medications
at discharge (aspirin, P2Y12
inhibitor, and statin) (N/A)
0964 Use of all recommended medications
(aspirin, P2Y12 inhibitor medication,
and statin) to reduce the chance of
blood clots and decrease cholesterol
after PCI/angioplasty.
Patients should be prescribed aspirin, a P2Y12 inhibitor
medication, and a statin medication after having a
PCI/angioplasty to reduce the chance of blood clots
in new stents, decrease cholesterol, and reduce the
risk of heart attacks—unless there is a reason not to
use these medicines (such as an allergy).
This score shows how well this facility is following this
guideline—higher is better. Patients who cannot take
a recommended medicine are excluded.
Terms, such as P2Y12, that may be unfamiliar to the public are all deﬁned in an online dictionary available to the public.
NQF ¼ National Quality Forum; PCI ¼ percutaneous coronary intervention; other abbreviations as in Table 1.
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209the NCDR are only at the hospital level, there is no
physician-level reporting. Data will be available to the
public on the ACC’s CardioSmart website, permitting
consumers to search by hospital name, address, zip
code, or cardiac services provided. The initial per-
formance measures reported are from the CathPCI
and ICD Registries and have been endorsed by the
National Quality Forum, a requirement for NCDR
public reporting at this time (Tables 2 and 3). Facilities
will have 30 days to preview information on their
individual, private, NCDR web-enabled dashboard
before deciding to release their information publicly.
Review of the STS public reporting effort shows that
not only the top tier programs choose to report
their results publicly, but also some facilities in the
lowest tier.
MINIMUM SAMPLE SIZE FOR REPORTING
A small minimum sample size encourages reporting
from each registry by most facilities. However,low-volume facilities will inevitably have more
variation with wider conﬁdence intervals around
point estimates, making identiﬁcation of truly su-
perior (or inferior) hospitals difﬁcult. For measures
in the CathPCI Registry, the minimum number of
records required to qualify for public reporting is 25
procedures annually. Analysis of national NCDR
data indicated this threshold excluded approxi-
mately 3% of facilities, allowing 97% of facilities to
be eligible for public reporting. For measures in the
ICD Registry, the minimum number of records
required to qualify for public reporting is 11 pro-
cedures annually. A minimum number of 25 cases
was considered, but at that level, approximately
30% of facilities would be disqualiﬁed from report-
ing due to low volume. Reducing the threshold to 11
cases annually allows more than 80% of facilities
to qualify for public reporting. Although this may
seem low, the 11 case threshold is consistent
with the requirements of the American College of
Surgeons National Surgical Quality Improvement
TABLE 3 Initial ICD Public Reporting Metrics
Metric (NCDR Number)
NQF Endorsed
Measure Number CardioSmart Title CardioSmart Description
Number of new ICD
implants (N/A)
Number of new ICD implant and ICD replacement
procedures performed during the calendar year.
The number of ICD implant procedures that a site
performs does not necessarily indicate higher
quality, but it may be an indication of how
experienced this site is with the procedure.
HF/LVSD: ACEI/ARB therapy
at discharge (4)
1522 Use of a medicine in the ACEi or ARB class to
improve heart function after ICD implant in
patients with less than normal heart function.
Patients with less than normal heart function should be
prescribed an ACEI or ARB medication after receiving
an ICD implant—unless there is a reason not to use
the medicine (such as an allergy). Use of this
medication may reduce the risk of death and hospital
readmission after this procedure. This score shows
how well this facility is following this guideline—higher
is better. Patients who cannot take an ACEI or ARB
are excluded from the calculation.
CAD/MI beta-blocker at
discharge (5)
1528 Use of a beta-blocker medication after ICD implant
in patients with a previous heart attack.
Patients who have experienced a previous heart attack
should be prescribed a beta-blocker medication
after receiving an ICD implant—unless there is a
reason not to use the medicine (such as an allergy).
Use of this medication may reduce the risk of death
and hospital readmission after this procedure. This
score shows how well this facility is following this
guideline—higher is better. Patients who cannot
take beta-blocker medicines are excluded from
the calculation.
HF/LVSD: beta-blocker at
discharge (6)
1529 Use of a beta-blocker medication after ICD implant
in patients with less than normal heart function.
Patients with less than normal heart function should be
prescribed a beta-blocker medication after receiving
an ICD implant—unless there is a reason not to use
the medicine (such as an allergy). Use of this
medication may reduce the risk of death and hospital
readmission after this procedure. This score shows
how well this facility is following this guideline—higher
is better. Patients who cannot take beta-blocker
medicines are excluded from the calculation.
Composite of all medications at
discharge (ACEI/ARB and
beta-blocker) (14)
0965 Use of all recommended medications (ACEI or ARB
and beta-blocker) to improve heart function and
blood pressure after ICD implant.
Patients should be prescribed an ACEI or ARB medication
and a beta-blocker medication after receiving an
ICD implant—unless there is a reason not to use these
medicines (such as an allergy). Use of these medications
may reduce the risk of death and hospital readmission
after this procedure. This score shows how well this
facility is following this guideline—higher is better.
Patients who cannot take a recommended medicine
are excluded.
Medical terms that may be unfamiliar to the public are all deﬁned in an online dictionary available to the public.
ACEI ¼ angiotensin-converting enzyme inhibitor; ARB ¼ angiotensin receptor blocker; CAD ¼ coronary artery disease; HF ¼ heart failure; LVSD ¼ left ventricular systolic dysfunction; MI ¼ myocardial
infarction; other abbreviations as in Tables 1 and 2.
Dehmer et al. J A C C V O L . 6 7 , N O . 2 , 2 0 1 6
NCDR Public Reporting Program J A N U A R Y 1 9 , 2 0 1 6 : 2 0 5 – 1 5
210Program and the requirements for reporting on
Hospital Compare.
STATISTICAL ANALYSIS AND DISPLAY
OF REPORTED VARIABLES
To address some of the uncertainty due to sample
size, a model-based approach was adopted rather
than using the actual observed fraction of eligible
patients who receive a therapy as the reported value.
The model provides an estimate of the hospital’s
probability of providing a therapy among patients
identiﬁed as eligible for the therapy. For example, if
a recommended drug were given to 10 of 11 patients
receiving an ICD at a facility, the computed (observed)performance score would be 91%. Because of the small
sample size, the computed score of 91% could be an
incorrect assessment of the facility’s true perfor-
mance, and the resulting conﬁdence intervals would
be wide. The model-based approach described in the
Online Appendix accounts for both the “noise” asso-
ciated with a small sample size and the similarities
among patients treated within the same hospital. The
model provides a mechanism to pool information that
is known about each hospital and what is known about
all hospitals, avoiding the “regression to the mean”
problem. Using this model, an individual hospital
with a small sample size and a score above the mean of
all hospitals is “pulled down” closer to the mean
score, whereas an individual hospital with a small
FIGURE 2 Example of CardioSmart Hospital Proﬁle Page
This demonstrates how an individual hospital will be displayed to the public. The facility shown is ﬁctitious. ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin
receptor blocker; GWTG ¼ Get With The Guidelines; ICD ¼ implantable cardioverter-deﬁbrillator; NCDR ¼ National Cardiovascular Data Registry; PCI ¼ percutaneous
coronary intervention.
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211sample size and a score below the mean of all hospitals
is “pulled up” closer to the mean score of all hospitals.
The amount a score is adjusted up or down by the
model depends on the number of cases it contributes.
This method better predicts future performance
than the point estimate provided by observed rates.
Although more challenging to explain to hospitals and
the public, this approach is commonly used in other
reporting efforts such as Hospital Compare and ad-
heres to standards for public reporting of outcome
measures (9,47). This is consistent with the ACC’s
position that the motivation behind public reporting
should be the promotion of best practices and
quality improvement rather than creating unjustiﬁed
apparent differentiation across facilities (7).The information provided in public reporting
should be understandable and usable. The amount of
information and manner in which it is displayed
determine whether consumers can actually process
and use it in decision-making (48,49). Information
displays that aid consumers in quickly understanding
the meaning of data increase consumer motivation to
use the information, in contrast to a bewildering
display that will quickly be dismissed as too compli-
cated. On the basis of recommendations from several
sources and the previously cited best practices for
public reporting documents, we adopted a 1 to 4 star-
rating scheme.
Once a facility’s performance score for a measure
is estimated from the model, the score is converted to
TABLE 4 NCDR Publ
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212a star rating for public display. To avoid confusion,
the same scheme for the star assignments of perfor-
mance scores is used throughout the reporting pro-
gram rather than using a different scheme for star
rating assignment for individual metrics. Among the
options considered to convert the modeled score to
stars, an absolute scoring option was chosen. The
primary beneﬁt of absolute performance scoring is
that performance scores are converted into star rat-
ings based on cut-points that were deemed clinically
relevant and that would yield meaningful clinical
differences between groups. However, a potential
drawback is the possibility to have no (or all) hospi-
tals assigned to a speciﬁc star tier, and thus,
this display could provide little discrimination be-
tween hospitals for the consumer. In addition,
there is subjectivity to the thresholds, as not all may
agree on clinically meaningful threshold values.
The cut points chosen for star assignments were:
1 star for a performance score <75%, 2 stars for per-
formance scores $75% but <90%, 3 stars for perfor-
mance scores $90% but <95% and 4 stars for a
performance score $95%.
DISPLAY OF UNCERTAINTY
The hierarchical model-based approach used in
reporting will adjust for some of the uncertainty in
the performance scores related to sample size.
Because scoring model accuracy depends on the
amount of data available, there will always be a
degree of uncertainty in the performance score of a
facility. The amount of uncertainty in a performance
score is high when the sample size is small and
decreases as the sample size increases. Uncertainty inic Reporting Mission Statement—March 2014
n of the Voluntary Hospital Public Reporting Program Is to
y of cardiovascular patient care being provided in a transparent
based on data that is of high quality, is administered with minimal
as cost-effectively as reasonable, and employs clinically valid and
ound measures.
that are actionable and consistent with the triple aim of better
are, and lower costs without causing unintended consequences in
any population.
that include aspects of care where the patient can be engaged as part
here there is clear evidence that individual patient engagement can
the care being provided.
ps of trust through collaboration between patients and their
team by presenting information that is credible, understandable,
discussions at the community level in improving not only the overall
d to individual patients, but the health and well-being of populations.
d cardiovascular professionals to advocate for policies at the federal
t support achieving the triple aim.a measurement is typically expressed by displaying
conﬁdence intervals that show the range of values
within which the actual score is contained at a chosen
level of probability. All of this information will be
accessible to the reader through additional links
available from the basic data display. A detailed dis-
cussion of the statistical methods is presented in the
Online Appendix, and a mock-up of the proposed
display of the metric performance page on Car-
dioSmart is provided (Figure 2).
NCDR DATA ACCURACY
For any public reporting program to be successful and
provide meaningful information to the public, it is
essential for the reported information to be accurate
and timely. Administrative data typically lags 1 to
2 years behind in reporting and may fail to accurately
characterize the target population of procedures,
resulting in the evaluation of a heterogeneous
cohort with misleading case numbers and mortality
rates (50,51). Critical clinical variables necessary
for adequate risk adjustment may be lacking, and
comorbidities may be confused with complications in
administrative data (52–54).
All incoming data from facilities participating in
the NCDR are subject to checks for data complete-
ness and consistency (55). Completeness focuses
on the proportion of missing data within ﬁelds,
whereas consistency determines the extent to which
logically related ﬁelds contain values consistent
with other ﬁelds. Accuracy of data is checked by
random independent chart audits to assess the
agreement between submitted registry data and the
contents of original charts from the hospitals sub-
mitting data. The accuracy of data entered is high,
although the number of audits annually is relatively
small compared with the volume of data being
entered. Concerns that some variables, especially
those used to characterize high-risk patients, are not
captured persist (44,45). As such, the variables
captured within the NCDR are routinely evaluated,
with speciﬁc attention to variables reﬂective of
elevated risk. Past NCDR risk models have demon-
strated high performance among high-risk patient
subsets (56).
THE FUTURE OF NCDR PUBLIC REPORTING
This ﬁrst iteration of public reporting by the ACC
follows the principles set forth in the NCDR public
reporting program mission statement (Table 4).
The NCDR acknowledges that this is only the initial
step in our public reporting program. There are
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213several important reasons for hospitals to participate
in the NCDR public reporting programs. First, the
public has a growing desire for this information; thus,
providing these NCDR data demonstrates a good faith
effort to deliver high-quality clinical data to assist
patients’ health care decisions. Second, value-driven
purchasing, which will include public access to pro-
vider performance, will be dominant within several
years. Failure to understand and use clinical data now
to improve operations may result in facilities falling
subject to public judgments based on administrative
or proprietary-derived data and falling behind in their
adaptation to the changing health care environment
(57). Finally, all major cardiovascular professional
organizations support patient advocacy, serve mem-
bers’ practice advancement, and promote quality
education programs for their members, and many
support clinical databases (8,10). These registries
use standardized, timely, benchmarked reports
to document best practices and outcomes and aid
participants to improve operations and services.
These data are also used for member recertiﬁcation
and the documentation of competencies. This
approach harmonizes into the value-purchasing
paradigm that is rapidly approaching.
The ACC recognizes that reporting alone is not
sufﬁcient to drive improvements in care delivery and
will continue to build Clinical Toolkits as part of the
Quality Improvement for Institutions initiative made
available at no cost to every NCDR participating
facility (10). NCDR data are used to identify gaps in
care as priority topics for toolkit development, and
the toolkit resources are focused to align speciﬁcally
with the patient care goals being measured through
NCDR.
Future public reporting using NCDR data may
include use of validated quality metrics, risk-
adjusted clinical outcomes, and composite quality
measures across NCDR registries. For some of these
outcome measures, it will be necessary to linkNCDR data to external databases to derive outcome
measures beyond hospital discharge. To that end,
the NCDR conducted a pilot program to report
30-day risk-standardized readmission after PCI.
The pilot required linking patients undergoing PCI
with data from Medicare on readmissions following
discharge from the index PCI. Among participating
CathPCI Registry facilities, 22% volunteered to have
their PCI readmission data displayed, including fa-
cilities with higher than expected readmission rates.
Enhanced search functions are also planned in
future updates.
CONCLUSIONS
The medical community continues to have an un-
derstandable degree of anxiety over the unintended
consequences of public reporting and the ability
of the public and others to misuse or misinterpret
the results. The ACC is ﬁrmly committed to devel-
oping a cardiovascular public reporting program
using high-quality clinical data that fairly and
accurately characterizes the care provided while
delivering usable and understandable informa-
tion to the public. Voluntary participation in
public reporting has the potential to enhance a
health care facility’s standing and linkage to the
community.
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